Home > D. General pathology > Blood and immunity > Bone marrow > TP53 deletion-associated multiple myeloma
TP53 deletion-associated multiple myeloma
Monday 20 November 2017
See also
TP53 deletion-associated tumors
multiple myeloma
Open references
Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion. Hao S, Lin P, Medeiros LJ, Fang L, Carballo-Zarate AA, Konoplev SN, Sargent RL, Weber DM, Thomas SK, Manasanch EE, Orlowski RZ, Lu X. Mod Pathol. 2017 Oct;30(10):1378-1386. doi : 10.1038/modpathol.2017.63
PMID: 28664940 Free
